Monte Financial Group’s AstraZeneca AZN Stock Holding History

Monte Financial Group’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.49M	Buy	9,252 +26	+0.3%	+$4.33K	0.5%	60
2026 Q2	$1.57M	Buy	9,226 +155	+2%	+$29.2K	0.5%	61
2026 Q1	$1.79M	Sell	9,071 -1,169	-11%	-$225K	0.64%	46
2025 Q4	$1.88M	Hold	10,240	–	–	0.7%	43
2025 Q3	$1.57M	Sell	10,240 -1,109	-10%	-$168K	0.58%	50
2025 Q2	$1.59M	Sell	11,349 -13	-0.1%	-$1.82K	0.62%	49
2025 Q1	$1.54M	Hold	11,362	–	–	0.67%	40
2024 Q4	$1.49M	Hold	11,362	–	–	0.64%	40
2024 Q3	$1.77M	Sell	11,362 -1,036	-8%	-$167K	0.73%	36
2024 Q2	$1.93M	Buy	12,398 +2,620	+27%	+$394K	0.85%	37
2024 Q1	$1.32M	Buy	+9,778	New	+$1.29M	0.58%	40

Other funds holding AZN

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Vanguard Asset Management London, Ec4n 8af $162B AUM

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

Monte Financial Group's AZN Position: Q3 2026 in Review

Monte Financial Group increased its AstraZeneca (AZN) stake by 0.28% in Q3 2026, buying an estimated $4.33K and bringing the position to 9,252 shares worth $1.49M. The position accounts for 0.5% of the portfolio, ranked #60.

Monte Financial Group first reported a position in AZN in Q1 2024 and has held it in 11 quarters since. The position peaked at $1.93M in Q2 2024. 1,222 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

Monte Financial Group held 9,252 shares of AstraZeneca worth $1.49M as of Q3 2026.
Monte Financial Group bought 26 AstraZeneca shares in Q3 2026, an estimated $4.33K.
AstraZeneca made up 0.5% of Monte Financial Group's portfolio in Q3 2026, its #60 holding.
Monte Financial Group first reported a position in AstraZeneca in Q1 2024 and has held it in 11 quarters since.
Monte Financial Group's AstraZeneca position peaked at $1.93M in Q2 2024.
1,222 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Monte Financial Group's 13F filing for Q3 2026, filed 2 Nov 2026.